Dutasteride

From Anthony Nolan Medical Guidelines
Revision as of 11:43, 19 June 2012 by Dr Robert Lown (talk | contribs) (Protected "Dutasteride" (‎[edit=sysop] (indefinite) ‎[move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Acceptability at Recruitment

ACCEPTABLE

Acceptability at CT / Work-Up

QUALIFIED

Individual at Risk

Recipient

Explanation of Condition

Drug interfering in the function of testosterone, usually given for prostate enlargement or prostate cancer.

Guidance

Inform TC if less than 6 months after taking dutasteride (Avodart). Discuss with MO.

Pseudonyms or Related Conditions

Avodart

Version

Version 1, Edition 1

Date of Last Update

15th June 2012

Retrieved from "https://www.med-guidelines.org.uk/index.php?title=Dutasteride&oldid=675"